BOC Sciences

"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological...

BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques. "We're happy to have achieved consensus with global pharmaceuticals to deal with the NDMA risk and other impurity concerns.

CDMO services are not new at BOC Sciences. Rather, as a reputed CDMO service provider, BOC Sciences has extensively contributed to the development and production of small molecules, oligonucleotides, peptides, various chemically coupled drugs, and...

BOC Sciences, a New York-based company with a long-term commitment to providing pharmaceutical discovery services and raw materials, recently introduces pharmaceutical impurity identification services to accelerate drug development.

BOC RNA, a sub-brand of BOC Sciences, has been contributing to the development of siRNA drug delivery system for years and provides a series of siRNA conjugates. siRNA drugs demonstrate promising prospects in clinical practice.

AAPEP, a sub-brand of BOC Sciences, is an experienced biochemistry company, which offers a complete range of amino acid products, including natural amino acids and unnatural amino acids, for chemical and biochemical laboratory and scientific use.

In the process of drug research, production, storage, and clinical application, its impurity contents must be reduced to ensure effectiveness and safety.

BOC Sciences, well known as the largest supplier of pseudoUridine in the world, announces that its yearly output currently surpasses 500 kg, indicating reliable efficiency and high productivity.

The principle of high-throughput drug screening is that drugs mostly re-adjust the patient's physiological state by specifically acting on target proteins (receptors, enzymes, ion channels, etc.).

BOC Sciences, a provider of CDMO services for the development of microbial drugs, recently announced that it has improved its fermentation CDMO platform to provide a comprehensive one-stop industrial fermentation CDMO service.